In fact, the Keap1–Nrf2 pathway plays in the protection of our body against drug toxicity and stress induced diseases, and cancer cells hijack Nrf2 activity to support their malignant growth and thus Nrf2 has emerged as a therapeutic target. This evidence concerns the gene KEAP1 and cancer.